FIBRINOGEN AS A RISK FACTOR FOR STROKE AND MYOCARDIAL-INFARCTION

被引：1632

作者：

WILHELMSEN, L

SVARDSUDD, K

KORSANBENGTSEN, K

LARSSON, B

WELIN, L

TIBBLIN, G

机构：

[1] SAHLGRENS HOSP,DEPT MED,S-41345 GOTHENBURG,SWEDEN

[2] GOTHENBURG UNIV,S-41124 GOTHENBURG,SWEDEN

来源：

关键词：

D O I：

10.1056/NEJM198408233110804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：501 / 505

页数：5

共 23 条

[1] [Anonymous], 1978, N ENGL J MED, V299, P53
[2] DETERMINATION OF PLASMINOGEN IN HUMAN PLASMA BY LYSIS TIME METHOD
BERG, W
KORSANBE.K
YGGE, J
[J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, 16 (1-2): : 1 - &
[3] BLOMBACK B, 1958, ARK KEMI, V12, P99
[4] PHYSIOLOGICAL MECHANISMS IN COAGULATION AND FIBRINOLYSIS
BROZOVIC, M
[J]. BRITISH MEDICAL BULLETIN, 1977, 33 (03) : 231 - 238
[5] ELMFELDT D, 1975, ACTA MED SCAND, V197, P497
[6] CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA
FIELDS, WS
LEMAK, NA
FRANKOWSKI, RF
HARDY, RJ
[J]. STROKE, 1977, 8 (03) : 301 - 316
[7] CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA .2. SURGICAL GROUP
FIELDS, WS
LEMAK, NA
FRANKOWSKI, RF
HARDY, RJ
[J]. STROKE, 1978, 9 (04) : 309 - 319
[8] HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[9] HARMSEN P, 1979, ACTA MED SCAND, V206, P337
[10] BLOOD-COAGULATION AND FIBRINOLYSIS IN MAN AFTER MYOCARDIAL-INFARCTION COMPARED WITH A REPRESENTATIVE POPULATION SAMPLE
KORSANBE.K
WILHELMS.L
TIBBLIN, G
ELMFELDT, D
[J]. ATHEROSCLEROSIS, 1972, 16 (01) : 83 - &